TABLE 2

The association between acute exacerbation (AEx) of idiopathic interstitial pneumonias and each suspected cytotoxic agent

AgentsPatientsAEx
Cisplatin9115 (16.5%)
Carboplatin25020 (8.0%)
Etoposide1247 (5.6%)
Paclitaxel14618 (12.3%)
Vinorelbine5110 (19.6%)
Docetaxel196 (31.6%)
Gemcitabine61 (16.7%)
Vindesine171 (5.9%)
UFT175 (29.4%)
 Platinum-based regimen34135 (10.3%)
 Nonplatinum-based regimen#4913 (26.5%)

UFT: tegafur-uracil. #: gefitinib was excluded.